At a time point at which 0/10 mice injected with the Atg5 WT ENL–MLL lines had neither developed clinical symptoms nor signs of leukemia, 10/10 mice injected with HET Atg5 MLL–ENL lines had to be killed because of typical leukemic clinical symptoms (Figure 3h). This evidence concerns the gene KMT2A and leukemia.